AddictionNews

Latest developments in causes and treatments

AddictionNews

AddictionNews

GLP-1 drugs

The Latest Research on Using GLP-1 Drugs to Battle Addiction

GLP-1 drugs in the treatment of addiction was a theme at the 56th annual conference of the American Society of Addiction Medicine (ASAM).

Lilly’s GLP-1 Pill Shines in Phase 3 Trial

GLP-1 drugs in pill form work as well as injectables in Lilly trial.

HDAC5 and the Epigenetics of Addiction

Two new studies explain the role of the epigenetic enzyme, HDAC5, in cocaine addiction and depression.

Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial

The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.

Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction

Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.

The Impact of GLP-1 Drugs on Reward Pathways

We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.